Earl Douglas

Insider Reports History

Entity
Individual
Location
Biomimetic Therapeutics, Inc., 389 Nichol Mill Lane, Franklin, TN
Signature
/s/Earl Douglas
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Earl Douglas:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Allogene Therapeutics, Inc. SVP, General Counsel Common Stock 449K $1.25M $2.79 Aug 21, 2024 Direct
Allogene Therapeutics, Inc. SVP, General Counsel Stock Option (Right to buy) 148K Jan 25, 2024 Direct

Insider Reports Filed by Earl Douglas

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ALLO Allogene Therapeutics, Inc. Aug 21, 2024 1 -$78.8K 4 Aug 23, 2024 SVP, General Counsel
ALLO Allogene Therapeutics, Inc. Jan 25, 2024 2 $0 4 Jan 31, 2024 SVP, General Counsel
ALLO Allogene Therapeutics, Inc. Aug 14, 2023 3 $0 4 Aug 17, 2023 GENERAL COUNSEL
ALLO Allogene Therapeutics, Inc. Aug 14, 2023 0 $0 3 Aug 17, 2023 GENERAL COUNSEL